A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
Patients must have had chicken pox. Cannot have had the chickenpox or shingles vaccination. Cannot have had shingles in the past year. This is a partial list of Inclusion criteria. Multiple other criteria must be met to be eligible for this clinical trial.